List of Tables
Table 1. Global Manmade Version of Somatostatin Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Manmade Version of Somatostatin Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Manmade Version of Somatostatin Market Competitive Situation by Manufacturers in 2025
Table 4. Global Manmade Version of Somatostatin Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Manmade Version of Somatostatin Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Manmade Version of Somatostatin Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Manmade Version of Somatostatin Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Manmade Version of Somatostatin Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Manmade Version of Somatostatin, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Manmade Version of Somatostatin, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Manmade Version of Somatostatin, Product Types and Applications
Table 12. Global Key Manufacturers of Manmade Version of Somatostatin, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Manmade Version of Somatostatin Companies by Tier (Tier 1, Tier 2, Tier 3), based on Manmade Version of Somatostatin Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Manmade Version of Somatostatin Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Manmade Version of Somatostatin Sales by Region (K Units), 2021–2026
Table 18. Global Manmade Version of Somatostatin Sales Market Share by Region (2021–2026)
Table 19. Global Manmade Version of Somatostatin Sales by Region (K Units), 2027–2032
Table 20. Global Manmade Version of Somatostatin Sales Market Share by Region (2027–2032)
Table 21. Global Manmade Version of Somatostatin Revenue by Region (US$ Million), 2021–2026
Table 22. Global Manmade Version of Somatostatin Revenue Market Share by Region (2021–2026)
Table 23. Global Manmade Version of Somatostatin Revenue by Region (US$ Million), 2027–2032
Table 24. Global Manmade Version of Somatostatin Revenue Market Share by Region (2027–2032)
Table 25. North America Manmade Version of Somatostatin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Manmade Version of Somatostatin Sales by Country (K Units), 2021–2026
Table 27. North America Manmade Version of Somatostatin Sales by Country (K Units), 2027–2032
Table 28. North America Manmade Version of Somatostatin Revenue by Country (US$ Million), 2021–2026
Table 29. North America Manmade Version of Somatostatin Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Manmade Version of Somatostatin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Manmade Version of Somatostatin Sales by Country (K Units), 2021–2026
Table 32. Europe Manmade Version of Somatostatin Sales by Country (K Units), 2027–2032
Table 33. Europe Manmade Version of Somatostatin Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Manmade Version of Somatostatin Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Manmade Version of Somatostatin Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Manmade Version of Somatostatin Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Manmade Version of Somatostatin Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Manmade Version of Somatostatin Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Manmade Version of Somatostatin Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Manmade Version of Somatostatin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Manmade Version of Somatostatin Sales by Country (K Units), 2021–2026
Table 42. Latin America Manmade Version of Somatostatin Sales by Country (K Units), 2027–2032
Table 43. Latin America Manmade Version of Somatostatin Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Manmade Version of Somatostatin Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Manmade Version of Somatostatin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Manmade Version of Somatostatin Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Manmade Version of Somatostatin Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Manmade Version of Somatostatin Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Manmade Version of Somatostatin Revenue by Country (US$ Million), 2027–2032
Table 50. Global Manmade Version of Somatostatin Sales (K Units) by Type (2021–2026)
Table 51. Global Manmade Version of Somatostatin Sales (K Units) by Type (2027–2032)
Table 52. Global Manmade Version of Somatostatin Sales Market Share by Type (2021–2026)
Table 53. Global Manmade Version of Somatostatin Sales Market Share by Type (2027–2032)
Table 54. Global Manmade Version of Somatostatin Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Manmade Version of Somatostatin Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Manmade Version of Somatostatin Revenue Market Share by Type (2021–2026)
Table 57. Global Manmade Version of Somatostatin Revenue Market Share by Type (2027–2032)
Table 58. Global Manmade Version of Somatostatin Price (US$/Unit) by Type (2021–2026)
Table 59. Global Manmade Version of Somatostatin Price (US$/Unit) by Type (2027–2032)
Table 60. Global Manmade Version of Somatostatin Sales (K Units) by Application (2021–2026)
Table 61. Global Manmade Version of Somatostatin Sales (K Units) by Application (2027–2032)
Table 62. Global Manmade Version of Somatostatin Sales Market Share by Application (2021–2026)
Table 63. Global Manmade Version of Somatostatin Sales Market Share by Application (2027–2032)
Table 64. Global Manmade Version of Somatostatin Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Manmade Version of Somatostatin Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Manmade Version of Somatostatin Revenue Market Share by Application (2021–2026)
Table 67. Global Manmade Version of Somatostatin Revenue Market Share by Application (2027–2032)
Table 68. Global Manmade Version of Somatostatin Price (US$/Unit) by Application (2021–2026)
Table 69. Global Manmade Version of Somatostatin Price (US$/Unit) by Application (2027–2032)
Table 70. Novartis Company Information
Table 71. Novartis Description and Business Overview
Table 72. Novartis Manmade Version of Somatostatin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Novartis Manmade Version of Somatostatin Product
Table 74. Novartis Recent Developments/Updates
Table 75. Ipsen Company Information
Table 76. Ipsen Description and Business Overview
Table 77. Ipsen Manmade Version of Somatostatin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Ipsen Manmade Version of Somatostatin Product
Table 79. Ipsen Recent Developments/Updates
Table 80. Recordati Rare Diseases Company Information
Table 81. Recordati Rare Diseases Description and Business Overview
Table 82. Recordati Rare Diseases Manmade Version of Somatostatin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Recordati Rare Diseases Manmade Version of Somatostatin Product
Table 84. Recordati Rare Diseases Recent Developments/Updates
Table 85. Chiesi Farmaceutici S.p.A Company Information
Table 86. Chiesi Farmaceutici S.p.A Description and Business Overview
Table 87. Chiesi Farmaceutici S.p.A Manmade Version of Somatostatin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Chiesi Farmaceutici S.p.A Manmade Version of Somatostatin Product
Table 89. Chiesi Farmaceutici S.p.A Recent Developments/Updates
Table 90. Advanz Pharma Company Information
Table 91. Advanz Pharma Description and Business Overview
Table 92. Advanz Pharma Manmade Version of Somatostatin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Advanz Pharma Manmade Version of Somatostatin Product
Table 94. Advanz Pharma Recent Developments/Updates
Table 95. Cipla Company Information
Table 96. Cipla Description and Business Overview
Table 97. Cipla Manmade Version of Somatostatin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Cipla Manmade Version of Somatostatin Product
Table 99. Cipla Recent Developments/Updates
Table 100. Teva Company Information
Table 101. Teva Description and Business Overview
Table 102. Teva Manmade Version of Somatostatin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Teva Manmade Version of Somatostatin Product
Table 104. Teva Recent Developments/Updates
Table 105. Gland Pharma Company Information
Table 106. Gland Pharma Description and Business Overview
Table 107. Gland Pharma Manmade Version of Somatostatin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Gland Pharma Manmade Version of Somatostatin Product
Table 109. Gland Pharma Recent Developments/Updates
Table 110. Heritage Pharmaceuticals Company Information
Table 111. Heritage Pharmaceuticals Description and Business Overview
Table 112. Heritage Pharmaceuticals Manmade Version of Somatostatin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Heritage Pharmaceuticals Manmade Version of Somatostatin Product
Table 114. Heritage Pharmaceuticals Recent Developments/Updates
Table 115. Sagent Pharmaceuticals Company Information
Table 116. Sagent Pharmaceuticals Description and Business Overview
Table 117. Sagent Pharmaceuticals Manmade Version of Somatostatin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Sagent Pharmaceuticals Manmade Version of Somatostatin Product
Table 119. Sagent Pharmaceuticals Recent Developments/Updates
Table 120. Sun Pharmaceutical Company Information
Table 121. Sun Pharmaceutical Description and Business Overview
Table 122. Sun Pharmaceutical Manmade Version of Somatostatin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Sun Pharmaceutical Manmade Version of Somatostatin Product
Table 124. Sun Pharmaceutical Recent Developments/Updates
Table 125. Fresenius Kabi Company Information
Table 126. Fresenius Kabi Description and Business Overview
Table 127. Fresenius Kabi Manmade Version of Somatostatin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Fresenius Kabi Manmade Version of Somatostatin Product
Table 129. Fresenius Kabi Recent Developments/Updates
Table 130. Mylan Company Information
Table 131. Mylan Description and Business Overview
Table 132. Mylan Manmade Version of Somatostatin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Mylan Manmade Version of Somatostatin Product
Table 134. Mylan Recent Developments/Updates
Table 135. West-Ward Pharmaceuticals Company Information
Table 136. West-Ward Pharmaceuticals Description and Business Overview
Table 137. West-Ward Pharmaceuticals Manmade Version of Somatostatin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. West-Ward Pharmaceuticals Manmade Version of Somatostatin Product
Table 139. West-Ward Pharmaceuticals Recent Developments/Updates
Table 140. Suzhou Tianma Pharmaceutical Company Information
Table 141. Suzhou Tianma Pharmaceutical Description and Business Overview
Table 142. Suzhou Tianma Pharmaceutical Manmade Version of Somatostatin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Suzhou Tianma Pharmaceutical Manmade Version of Somatostatin Product
Table 144. Suzhou Tianma Pharmaceutical Recent Developments/Updates
Table 145. Sihuan Pharmaceutical Company Information
Table 146. Sihuan Pharmaceutical Description and Business Overview
Table 147. Sihuan Pharmaceutical Manmade Version of Somatostatin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 148. Sihuan Pharmaceutical Manmade Version of Somatostatin Product
Table 149. Sihuan Pharmaceutical Recent Developments/Updates
Table 150. Chengdu Tiantaishan pharmaceutical Company Information
Table 151. Chengdu Tiantaishan pharmaceutical Description and Business Overview
Table 152. Chengdu Tiantaishan pharmaceutical Manmade Version of Somatostatin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 153. Chengdu Tiantaishan pharmaceutical Manmade Version of Somatostatin Product
Table 154. Chengdu Tiantaishan pharmaceutical Recent Developments/Updates
Table 155. Hybio Pharmaceutical Company Information
Table 156. Hybio Pharmaceutical Description and Business Overview
Table 157. Hybio Pharmaceutical Manmade Version of Somatostatin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 158. Hybio Pharmaceutical Manmade Version of Somatostatin Product
Table 159. Hybio Pharmaceutical Recent Developments/Updates
Table 160. Hainan Shuangcheng Pharmaceuticals Company Information
Table 161. Hainan Shuangcheng Pharmaceuticals Description and Business Overview
Table 162. Hainan Shuangcheng Pharmaceuticals Manmade Version of Somatostatin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 163. Hainan Shuangcheng Pharmaceuticals Manmade Version of Somatostatin Product
Table 164. Hainan Shuangcheng Pharmaceuticals Recent Developments/Updates
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Manmade Version of Somatostatin Distributors List
Table 168. Manmade Version of Somatostatin Customers List
Table 169. Manmade Version of Somatostatin Market Trends
Table 170. Manmade Version of Somatostatin Market Drivers
Table 171. Manmade Version of Somatostatin Market Challenges
Table 172. Manmade Version of Somatostatin Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
Table 176. Authors List of This Report
List of Figures
Figure 1. Product Picture of Manmade Version of Somatostatin
Figure 2. Global Manmade Version of Somatostatin Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Manmade Version of Somatostatin Market Share by Type: 2025 & 2032
Figure 4. Octreotide Product Picture
Figure 5. Lanreotide Product Picture
Figure 6. Pasireotide Product Picture
Figure 7. Other Product Picture
Figure 8. Global Manmade Version of Somatostatin Market Value by Application (US$ Million), 2021–2032
Figure 9. Global Manmade Version of Somatostatin Market Share by Application: 2025 & 2032
Figure 10. Neuroendocrine Tumors
Figure 11. Acromegaly
Figure 12. Cushing Syndrome
Figure 13. Other
Figure 14. Global Manmade Version of Somatostatin Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Manmade Version of Somatostatin Market Size (US$ Million), 2021–2032
Figure 16. Global Manmade Version of Somatostatin Sales (K Units), 2021–2032
Figure 17. Global Manmade Version of Somatostatin Average Price (US$/Unit), 2021–2032
Figure 18. Manmade Version of Somatostatin Report Years Considered
Figure 19. Manmade Version of Somatostatin Sales Share by Manufacturers in 2025
Figure 20. Global Manmade Version of Somatostatin Revenue Share by Manufacturers in 2025
Figure 21. Top 5 and Top 10 Global Manmade Version of Somatostatin Players: Market Share by Revenue in Manmade Version of Somatostatin in 2025
Figure 22. Manmade Version of Somatostatin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 23. Global Manmade Version of Somatostatin Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 24. North America Manmade Version of Somatostatin Sales Market Share by Country (2021–2032)
Figure 25. North America Manmade Version of Somatostatin Revenue Market Share by Country (2021–2032)
Figure 26. United States Manmade Version of Somatostatin Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Canada Manmade Version of Somatostatin Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. Europe Manmade Version of Somatostatin Sales Market Share by Country (2021–2032)
Figure 29. Europe Manmade Version of Somatostatin Revenue Market Share by Country (2021–2032)
Figure 30. Germany Manmade Version of Somatostatin Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. France Manmade Version of Somatostatin Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. U.K. Manmade Version of Somatostatin Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Italy Manmade Version of Somatostatin Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Russia Manmade Version of Somatostatin Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Asia Pacific Manmade Version of Somatostatin Sales Market Share by Region (2021–2032)
Figure 36. Asia Pacific Manmade Version of Somatostatin Revenue Market Share by Region (2021–2032)
Figure 37. China Manmade Version of Somatostatin Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Japan Manmade Version of Somatostatin Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. South Korea Manmade Version of Somatostatin Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. India Manmade Version of Somatostatin Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Australia Manmade Version of Somatostatin Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. China Taiwan Manmade Version of Somatostatin Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Southeast Asia Manmade Version of Somatostatin Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Latin America Manmade Version of Somatostatin Sales Market Share by Country (2021–2032)
Figure 45. Latin America Manmade Version of Somatostatin Revenue Market Share by Country (2021–2032)
Figure 46. Mexico Manmade Version of Somatostatin Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Brazil Manmade Version of Somatostatin Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Argentina Manmade Version of Somatostatin Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Colombia Manmade Version of Somatostatin Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Middle East and Africa Manmade Version of Somatostatin Sales Market Share by Country (2021–2032)
Figure 51. Middle East and Africa Manmade Version of Somatostatin Revenue Market Share by Country (2021–2032)
Figure 52. Turkey Manmade Version of Somatostatin Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Saudi Arabia Manmade Version of Somatostatin Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. UAE Manmade Version of Somatostatin Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Global Sales Market Share of Manmade Version of Somatostatin by Type (2021–2032)
Figure 56. Global Revenue Market Share of Manmade Version of Somatostatin by Type (2021–2032)
Figure 57. Global Manmade Version of Somatostatin Price (US$/Unit) by Type (2021–2032)
Figure 58. Global Sales Market Share of Manmade Version of Somatostatin by Application (2021–2032)
Figure 59. Global Revenue Market Share of Manmade Version of Somatostatin by Application (2021–2032)
Figure 60. Global Manmade Version of Somatostatin Price (US$/Unit) by Application (2021–2032)
Figure 61. Manmade Version of Somatostatin Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
